AskZHealth TriNav® Newsletter Volume 1 Issue 1: Coding for "Nontarget" Embolization During the Phases of Liver Tumor Workup and Radioembolization
The therapeutic treatment of liver tumors using yttrium-90 (Y-90) radioembolization brings with it several unique coding challenges. Documentation is critical to capturing the key components of this complex interventional radiology (IR) / interventional oncology (IO) procedure. This article will focus on the embolization portion, beginning with coding basics and then transition into specific coding scenarios related to embolization performed during the phases of liver tumor workup and radioembolization.
Coding is always changing. Stay up to date on the latest coding and reimbursement information for the TriNav product line that we post here by signing up for our contact list:
Need to Ask a Question?
We're here for you! Didn't find your answer in the FAQ?
Ask the experts at AskZHealth
The materials and information on this website and any information provided in response to inquiries made through this website (collectively, the “Content”) represent the opinions of TriSalus Life Sciences, Inc. (“TriSalus”) and its contractor ZHealth, LLC (“ZHealth”). There can be no assurance that the Content is accurate in all respects or will remain accurate in the future, nor that any payer or governmental entity will agree with the information provided in the Content or will reimburse in accordance therewith. You are responsible for independently deciding on the proper billing codes and procedures for any payment claim.
THE CONTENT IS PROVIDED FREE OF CHARGE AND AS-IS, AND TRISALUS DISCLAIMS, ON BEHALF OF ITSELF AND , ZHEALTH, ANY AND ALL WARRANTIES AND REPRESENTATIONS (EXPRESS OR IMPLIED, ORAL OR WRITTEN), WITH RESPECT TO THE MATERIALS OR ANY PART THEREOF, INCLUDING ANY AND ALL IMPLIED WARRANTIES OR REPRESENTATIONS OF TITLE, NONINFRINGEMENT, MERCHANTABILITY, OR FITNESS OR SUITABILITY FOR ANY PURPOSE (WHETHER OR NOT TRISALUS OR ZHEALTH KNOWS, HAS REASON TO KNOW, HAS BEEN ADVISED, OR OTHERWISE IS IN FACT AWARE OF ANY SUCH PURPOSE), WHETHER ALLEGED TO ARISE BY LAW, BY REASON OF CUSTOM OR USAGE IN THE TRADE, BY COURSE OF DEALING, OR OTHERWISE. BY USING THIS WEBSITE AND THE CONTENT, YOU AGREE THAT NEITHER TRISALUS NOR ZHEALTH SHALL HAVE ANY LIABILITY FOR SUCH USE OR FOR THE CONTENT, ALL OF WHICH IS DISCLAIMED.
By using this website or the Content, you represent that you have read, and you expressly agree to, the Terms of Use [link] and you acknowledge the Privacy Policy of TriSalus. TriSalus may change or replace the Terms of Use and Privacy Policy from time to time, so you are advised to review these each time you visit this website.
Current Procedural Terminology (CPT®) is a trademark owned by the American Medical Association (THE “AMA”). To the extent that the Content contains or refers to CPT Codes, no endorsement of the Content by the AMA is made or implied, and any such endorsement and any liability on the part of the AMA are disclaimed.
